BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1946543)

  • 1. Chemicals, cell proliferation, risk estimation, and multistage carcinogenesis.
    Pitot HC; Dragan YP; Neveu MJ; Rizvi TA; Hully JR; Campbell HA
    Prog Clin Biol Res; 1991; 369():517-32. PubMed ID: 1946543
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of somatic mutations and cell replication kinetics in quantitative cancer risk assessment.
    Moolgavkar SH; Luebeck EG
    Prog Clin Biol Res; 1991; 369():469-79. PubMed ID: 1835095
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemically induced cell proliferation and carcinogenesis: differential effect of compensatory cell proliferation and mitogen-induced direct hyperplasia on hepatocarcinogenesis in the rat.
    Columbano A; Ledda-Columbano GM; Coni P; Pichiri-Coni G; Curto M; Pani P
    Prog Clin Biol Res; 1991; 369():217-25. PubMed ID: 1946520
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemically induced cell proliferation in liver carcinogenesis.
    Popp JA; Marsman DS
    Prog Clin Biol Res; 1991; 369():389-95. PubMed ID: 1946534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitogenesis and programmed cell death as determinants of carcinogenicity of nongenotoxic compounds.
    Schulte-Hermann R; Bursch W; Parzefall W
    Prog Clin Biol Res; 1991; 369():237-44. PubMed ID: 1946522
    [No Abstract]   [Full Text] [Related]  

  • 6. Liver carcinogenesis is not a predicted outcome of chemically induced hepatocyte proliferation.
    Melnick RL; Huff J
    Toxicol Ind Health; 1993; 9(3):415-38. PubMed ID: 8367884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemically induced cell proliferation in carcinogenesis in the male rat kidney.
    Short BG; Swenberg JA
    Prog Clin Biol Res; 1991; 369():357-67. PubMed ID: 1946532
    [No Abstract]   [Full Text] [Related]  

  • 8. Peroxisome proliferators: potential role of altered hepatocyte growth and differentiation in tumor development.
    Cattley RC; Miller RT; Corton JC
    Prog Clin Biol Res; 1995; 391():295-303. PubMed ID: 8532723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporating cell proliferation in quantitative cancer risk assessment: approaches, issues, and uncertainties.
    Chen C; Farland W
    Prog Clin Biol Res; 1991; 369():481-99. PubMed ID: 1946541
    [No Abstract]   [Full Text] [Related]  

  • 10. Ornithine decarboxylase induction and DNA damage as a predictive assay for potential carcinogenicity.
    Kitchin KT; Brown JL; Kulkarni AP
    Prog Clin Biol Res; 1991; 369():137-44. PubMed ID: 1946513
    [No Abstract]   [Full Text] [Related]  

  • 11. Liver tumor promoters and other mouse liver carcinogens.
    Ward JM; Diwan BA; Lubet RA; Henneman JR; Devor DE
    Prog Clin Biol Res; 1990; 331():85-108. PubMed ID: 2179967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver tumor promoter phenobarbital: a biphasic modulator of hepatocyte proliferation.
    Jirtle RL; Meyer SA; Brockenbrough JS
    Prog Clin Biol Res; 1991; 369():209-16. PubMed ID: 1946518
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemically induced cell proliferation in upper respiratory tract carcinogenesis.
    Monticello TM; Renne R; Morgan KT
    Prog Clin Biol Res; 1991; 369():323-35. PubMed ID: 1946528
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of hyperplasia in liver carcinogenesis.
    Mirsalis JC; Steinmetz KL
    Prog Clin Biol Res; 1990; 331():149-61. PubMed ID: 2179957
    [No Abstract]   [Full Text] [Related]  

  • 15. Control of hepatocyte proliferation in regeneration, augmentative hepatomegaly, and neoplasia.
    Michalopoulos G
    Prog Clin Biol Res; 1991; 369():227-36. PubMed ID: 1946521
    [No Abstract]   [Full Text] [Related]  

  • 16. Chloroform mode of action: implications for cancer risk assessment.
    Golden RJ; Holm SE; Robinson DE; Julkunen PH; Reese EA
    Regul Toxicol Pharmacol; 1997 Oct; 26(2):142-55. PubMed ID: 9356278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Normal cell proliferation and carcinogenesis].
    Harbers E
    Dtsch Med Wochenschr; 1991 Feb; 116(7):278-9. PubMed ID: 1993445
    [No Abstract]   [Full Text] [Related]  

  • 18. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case study of cancer data set combinations for PCBs.
    Vater ST; Velazquez SF; Cogliano VJ
    Regul Toxicol Pharmacol; 1995 Aug; 22(1):2-10. PubMed ID: 7494898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary on "Evaluation of possible carcinogenic risk to humans based on liver tumors in rodent assays: the two-year bioassay is no longer necessary".
    Long GG
    Toxicol Pathol; 2010 Apr; 38(3):502-5. PubMed ID: 20124495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.